Literature DB >> 23811805

Desmoplastic melanoma: recent advances and persisting challenges.

Benjamin A Wood1.   

Abstract

Desmoplastic melanoma is an uncommon variant of melanoma which presents significant challenges to the clinician and histopathologist. In particular, many cases show a bland 'fibroblastic' appearance, mimicking scar and a range of other benign proliferations. This diagnosis can be particularly problematic in small biopsy specimens, a difficulty exacerbated by an immunoprofile which is typically negative for a number of conventional melanocytic markers. The clinical and histological features of desmoplastic melanoma are reviewed, as are the differential diagnoses and some newer techniques which may contribute to assessment of these lesions. In recent years it has become clear that subclassification of desmoplastic melanoma into pure and mixed variants has clinical significance and it is suggested that this classification be employed in routine practice.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23811805     DOI: 10.1097/PAT.0b013e3283631c96

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  3 in total

1.  Pure and Mixed Desmoplastic Melanomas: A Retrospective Clinicopathologic Comparison of 33 Cases.

Authors:  Sherman Chu; Kory P Schrom; Raghav Tripathi; Rosalynn R Z Conic; Harib H Ezaldein; Jeffrey F Scott; Kord Honda
Journal:  Am J Dermatopathol       Date:  2021-11-01       Impact factor: 1.319

2.  Desmoplastic Melanoma: Clinical Characteristics and Survival in the US Population.

Authors:  Maria T Huayllani; Andrea Sisti; David J Restrepo; Daniel Boczar; Jordan J Cochuyt; Aaron C Spaulding; Sanjay P Bagaria; Brian D Rinker; Antonio J Forte
Journal:  Cureus       Date:  2019-06-18

3.  Correlative study of epigenetic regulation of tumor microenvironment in spindle cell melanomas and cutaneous malignant peripheral nerve sheath tumors.

Authors:  Theodore Vougiouklakis; Phyu P Aung; Varshini Vasudevaraja; Victor G Prieto; Carlos A Torres-Cabala; Erik P Sulman; Matija Snuderl; George Jour
Journal:  Sci Rep       Date:  2020-08-03       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.